Persistent Vomiting and Reflux 12 Years After Sleeve Gastrectomy
You need urgent evaluation for anatomic complications—persistent vomiting and reflux 12 years post-sleeve gastrectomy is not normal and requires investigation for gastric stenosis, hiatal hernia, or consideration of conversion to Roux-en-Y gastric bypass, which is the only proven treatment for intractable reflux after sleeve gastrectomy. 1
Why This Is Happening After 12 Years
Sleeve gastrectomy causes progressive anatomic and functional changes that worsen over time:
Your lower esophageal sphincter (LES) pressure has likely deteriorated—patients with reflux symptoms after sleeve gastrectomy show LES resting pressures of only 9.8 ± 2.1 mmHg compared to 13.3 ± 4.2 mmHg in those without symptoms 2
Late anatomic changes are common—65.1% of sleeve gastrectomy patients develop reflux symptoms at long-term follow-up, with 77.5% showing positive acid reflux tests and mean DeMeester scores of 41.7 2
The gastric remnant may have migrated into your chest—intrathoracic migration of the remnant stomach is a recognized late complication that worsens reflux 3
Your gastric remnant has reduced compliance—this provokes increased transient LES relaxations and creates a higher gastroesophageal pressure gradient 3
Serious Complications You Must Rule Out Immediately
Do not dismiss persistent vomiting as "normal" post-sleeve symptoms:
Gastric stenosis is a recognized cause of severe dysphagia and vomiting after sleeve gastrectomy and requires endoscopic evaluation 4
Hiatal hernia occurs in 5.7% of long-term sleeve patients and significantly worsens reflux 2
Barrett's esophagus develops in 4.8% of patients at late follow-up after sleeve gastrectomy 2
Esophagitis is found in 29.4% of patients during endoscopy at long-term follow-up 2
Required Diagnostic Workup
You need comprehensive evaluation beyond just symptom management:
Upper endoscopy to assess for esophagitis, Barrett's esophagus, gastric stenosis, and hiatal hernia 2
24-hour pH monitoring to quantify acid exposure—this is positive in 77.5% of symptomatic patients with mean DeMeester scores reaching 41.7 2
Esophageal manometry to measure your LES pressure and esophageal motility 2
Barium esophagogram to evaluate for anatomic abnormalities, gastric remnant migration, and hiatal hernia 2, 3
Why Your Current Medical Therapy May Be Insufficient
Medical management alone often fails for post-sleeve reflux:
57.7% of sleeve gastrectomy patients require long-term PPI therapy, yet many remain symptomatic despite treatment 2
Vonoprazan and sucralfate address acid but not the anatomic problem—the fundamental issue is mechanical (low LES pressure, altered anatomy, increased gastroesophageal pressure gradient) 2, 3
Persistent vomiting for >2-3 weeks requires thiamine supplementation to prevent neurological complications, regardless of your other treatments 4
Definitive Treatment Options
The only proven cure for intractable reflux after sleeve gastrectomy is surgical revision:
Conversion to Roux-en-Y gastric bypass is the only proven method for treating intractable reflux after sleeve gastrectomy 1
If hiatal hernia is present, repair with posterior hiatoplasty may improve symptoms 5
Magnetic sphincter augmentation or radiofrequency ablation are alternative options that supplement LES anatomy, though evidence is limited compared to bypass conversion 1
Critical Pitfalls to Avoid
Persistent symptoms 12 years out warrant aggressive investigation:
Do not accept this as "normal" post-sleeve symptoms—the duration and persistence suggest anatomic complications requiring intervention 4, 2
Check for thiamine deficiency immediately—persistent vomiting puts you at high risk for rapid-onset neurological damage, and IV thiamine should be given empirically while awaiting lab confirmation 4, 6
Monitor hydration aggressively—dehydration both causes and exacerbates vomiting and reflux symptoms 4, 7
Ensure adequate protein intake of 60-80 g/day—chronic vomiting leads to protein-energy malnutrition 4
Do not delay endoscopy—Barrett's esophagus develops in nearly 5% of long-term sleeve patients and requires surveillance 2